Siemens Healthineers, a global leader in medical technology, is planning to exit its investment in the American Oncology Institute (AOI), a Hyderabad-based cancer care chain valued between ₹1,500-2,000 crore (approximately $180-240 million USD). This decision is part of Siemens' broader strategy to streamline its operations and focus on core assets. AOI operates 16 hospitals across India and a facility in Sri Lanka, partnering with notable hospital groups like Fortis in Punjab. The Indian cancer care market is rapidly expanding, currently valued at around ₹1.25 lakh crore and projected to grow at a 10-12% CAGR in the coming years. This growth is driven by a rising incidence of cancer, with estimates suggesting that actual cases may be up to three times higher than the officially recorded 2 million new detections in 2022. The increasing demand for affordable and advanced cancer treatment options is attracting significant private investment in specialized facilities. Investment bank Alvarez & Marsal is advising Siemens on the potential sale, with non-binding bids expected by the end of June.